Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -13.50% is 61% above its 5-year average of -34.94%, near the high end of its 5-year range (-68.43%–-10.20%).
11.93% above its 12-month average of -15.33%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): -12.07%.
NET PROFIT MARGIN
-13.50%
NET PROFIT MARGIN AVG TTM
-15.33%
NET PROFIT MARGIN AVG 3Y
-25.46%
NET PROFIT MARGIN AVG 5Y
-34.94%
NET PROFIT MARGIN AVG 10Y
-36.42%
NET PROFIT MARGIN AVG 15Y
-27.40%
NET PROFIT MARGIN AVG 20Y
-25.56%
CURRENT VS TTM AVG
+11.93%
CURRENT VS 3Y AVG
+46.98%
CURRENT VS 5Y AVG
+61.36%
CURRENT VS 10Y AVG
+62.93%
CURRENT VS 15Y AVG
+50.74%
CURRENT VS 20Y AVG
+47.19%
SECTOR MEDIAN · HEALTHCARE
-0.35%
median of 862 covered companies
CURRENT VS SECTOR MEDIAN
-3757.14%
vs the sector median at left
Alphatec Holdings, Inc.
Market Cap
$1.62B
Net Profit Margin
-13.50%
TTM Avg
-15.33%
3Y Avg
-25.46%
5Y Avg
-34.94%
Market Cap
$1.63B
Net Profit Margin
10.82%
TTM Avg
2.93%
3Y Avg
-1.36%
5Y Avg
-5.99%
Market Cap
$1.61B
Net Profit Margin
-24.51%
TTM Avg
-3392.63%
3Y Avg
-1004.26%
5Y Avg
-1004.26%
Market Cap
$1.61B
Net Profit Margin
-579.10%
TTM Avg
-408.42%
3Y Avg
-273.23%
5Y Avg
-333.72%
Market Cap
$1.60B
Net Profit Margin
-1350.73%
TTM Avg
-1059.67%
3Y Avg
-1046.38%
5Y Avg
-742.65%
Market Cap
$1.59B
Net Profit Margin
-140.43%
TTM Avg
-164.31%
3Y Avg
-442.76%
5Y Avg
-354.21%
Market Cap
$1.57B
Net Profit Margin
-753.60%
TTM Avg
-123.57%
3Y Avg
-563.59%
5Y Avg
-375.72%
Market Cap
$1.70B
Net Profit Margin
-48438.40%
TTM Avg
-3458.57%
3Y Avg
-1747.85%
5Y Avg
-1747.85%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Alphatec Holdings, Inc. (ATEC) | $1.62B | -13.50% | -15.33% | -25.46% | -34.94% |
| ANI Pharmaceuticals, Inc. (ANIP)vs › | $1.63B | 10.82% | 2.93% | -1.36% | -5.99% |
| Omnicell, Inc. (OMCL)vs › | $1.61B | 3.13% | 0.65% | -0.01% | 1.74% |
| Septerna Inc (SEPN)vs › | $1.61B | -24.51% | -3392.63% | -1004.26% | -1004.26% |
| Ocular Therapeutix, Inc. (OCUL)vs › | $1.61B | -579.10% | -408.42% | -273.23% | -333.72% |
| uniQure N.V. (QURE)vs › | $1.60B | -1350.73% | -1059.67% | -1046.38% | -742.65% |
| Kestra Medical Technologies, Ltd. (KMTS)vs › | $1.59B | -140.43% | -164.31% | -442.76% | -354.21% |
| Stoke Therapeutics, Inc. (STOK)vs › | $1.57B | -753.60% | -123.57% | -563.59% | -375.72% |
| Zenas BioPharma, Inc. (ZBIO)vs › | $1.70B | -48438.40% | -3458.57% | -1747.85% | -1747.85% |
| Syndax Pharmaceuticals, Inc. (SNDX)vs › | $1.54B | -87.60% | -755.85% | -377.93% | -1051.76% |
Operating Margin
-5.5%
Net Profit Margin
-13.5%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | -12.07% |
| 2026-03-31 | -17.65% |
| 2025-12-31 | -10.20% |
| 2025-09-30 | -14.54% |
| 2025-06-30 | -22.17% |
| 2025-03-31 | -30.68% |
| 2024-12-31 | -18.85% |
| 2024-09-30 | -26.28% |
| 2024-06-30 | -27.94% |
| 2024-03-31 | -35.02% |
| 2023-12-31 | -35.57% |
| 2023-09-30 | -36.07% |
| 2023-06-30 | -43.94% |
| 2023-03-31 | -39.89% |
| 2022-12-31 | -33.02% |
| 2022-09-30 | -40.95% |
| 2022-06-30 | -44.35% |
| 2022-03-31 | -60.40% |
| 2021-12-31 | -54.33% |
| 2021-09-30 | -68.43% |
| 2021-06-30 | -61.37% |
| 2021-03-31 | -51.91% |
| 2020-12-31 | -60.97% |
| 2020-09-30 | -38.07% |
| 2020-06-30 | -53.34% |
| 2020-03-31 | -68.81% |
| 2019-12-31 | -52.64% |
| 2019-09-30 | -49.89% |
| 2019-06-30 | -45.52% |
| 2019-03-31 | -52.81% |
| 2018-12-31 | -41.94% |
| 2018-09-30 | -40.67% |
| 2018-06-30 | -32.10% |
| 2018-03-31 | -8.99% |
| 2017-12-31 | 34.45% |
| 2017-09-30 | -13.58% |
| 2017-06-30 | -11.06% |
| 2017-03-31 | -19.71% |
| 2016-12-31 | -17.52% |
| 2016-09-30 | -51.37% |
| 2016-06-30 | -11.95% |
| 2016-03-31 | -14.78% |
| 2015-12-31 | -21.07% |
| 2015-09-30 | -372.74% |
| 2015-06-30 | -8.46% |
| 2015-03-31 | -9.38% |
| 2014-12-31 | -0.51% |
| 2014-09-30 | -5.96% |
| 2014-06-30 | -5.45% |
| 2014-03-31 | -13.57% |
| 2013-12-31 | -113.84% |
| 2013-09-30 | -28.91% |
| 2013-06-30 | -9.14% |
| 2013-03-31 | -5.25% |
| 2012-12-31 | -10.15% |
| 2012-09-30 | -5.27% |
| 2012-06-30 | -13.21% |
| 2012-03-31 | -2.60% |
| 2011-12-31 | -32.25% |
| 2011-09-30 | -2.74% |
| 2011-06-30 | -5.98% |
| 2011-03-31 | -3.76% |
| 2010-12-31 | -6.25% |
| 2010-09-30 | -8.45% |
| 2010-06-30 | -6.56% |
| 2010-03-31 | -12.26% |
| 2009-12-31 | -3.61% |
| 2009-09-30 | -3.93% |
| 2009-06-30 | -19.54% |
| 2009-03-31 | -14.32% |
| 2008-12-31 | -17.78% |
| 2008-09-30 | -18.83% |
| 2008-06-30 | -15.05% |
| 2008-03-31 | -68.02% |
| 2007-12-31 | -52.70% |
| 2007-09-30 | -27.45% |
| 2007-06-30 | -3.74% |
| 2007-03-31 | -13.68% |
| 2006-12-31 | -58.99% |
| 2006-09-30 | -31.33% |
| 2006-06-30 | -16.36% |
| 2006-03-31 | -32.59% |
| 2005-12-31 | -26.45% |
| 2005-09-30 | -26.45% |
| 2005-06-30 | -26.45% |
| 2005-03-31 | -67.87% |
| 2004-12-31 | 2.86% |
| 2004-09-30 | 2.86% |
| 2004-06-30 | 2.86% |
| 2004-03-31 | 2.86% |
